To account for this wide variability, we conducted a Bayesian analysis to estimate the difference in the average abundances of beta glucuronidase positive bacteria indicating 74% probability that breast cancer subjects have higher average beta glucuronidase levels (Supplementary Figure 6). The gene discussed is GUSB; the disease is breast carcinoma.